vs
百利高（PRGO）与Reddit, Inc.（RDDT）财务数据对比。点击上方公司名可切换其他公司
百利高的季度营收约是Reddit, Inc.的1.5倍（$1.1B vs $725.6M），Reddit, Inc.净利率更高（34.7% vs -127.8%，领先162.5%），Reddit, Inc.同比增速更快（69.7% vs -2.5%），Reddit, Inc.自由现金流更多（$263.6M vs $148.6M），过去两年Reddit, Inc.的营收复合增速更高（72.8% vs 1.3%）
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
Reddit是美国知名的社交新闻聚合与论坛类社交媒体平台，注册用户可发布链接、文字帖、图片、视频等各类内容，其他用户可对内容进行点赞或点踩，内容按主题归类到用户创建的子板块中，获赞更高的内容会排在板块前列，热度足够的内容还将展示在全站首页。
PRGO vs RDDT — 直观对比
营收规模更大
PRGO
是对方的1.5倍
$725.6M
营收增速更快
RDDT
高出72.2%
-2.5%
净利率更高
RDDT
高出162.5%
-127.8%
自由现金流更多
RDDT
多$115.0M
$148.6M
两年增速更快
RDDT
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $725.6M |
| 净利润 | $-1.4B | $251.6M |
| 毛利率 | 32.6% | 91.9% |
| 营业利润率 | -116.0% | 31.9% |
| 净利率 | -127.8% | 34.7% |
| 营收同比 | -2.5% | 69.7% |
| 净利润同比 | -3093.9% | 254.2% |
| 每股收益（稀释后） | $-10.23 | $1.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRGORDDT
| Q4 25 | $1.1B | $725.6M | ||
| Q3 25 | $1.0B | $584.9M | ||
| Q2 25 | $1.1B | $499.6M | ||
| Q1 25 | $1.0B | $392.4M | ||
| Q4 24 | $1.1B | $427.7M | ||
| Q3 24 | $1.1B | $348.4M | ||
| Q2 24 | $1.1B | $281.2M | ||
| Q1 24 | $1.1B | $243.0M |
净利润PRGORDDT
| Q4 25 | $-1.4B | $251.6M | ||
| Q3 25 | $7.5M | $162.7M | ||
| Q2 25 | $-8.4M | $89.3M | ||
| Q1 25 | $-6.4M | $26.2M | ||
| Q4 24 | $-44.4M | $71.0M | ||
| Q3 24 | $-21.0M | $29.9M | ||
| Q2 24 | $-108.4M | $-10.1M | ||
| Q1 24 | $2.0M | $-575.1M |
毛利率PRGORDDT
| Q4 25 | 32.6% | 91.9% | ||
| Q3 25 | 36.1% | 91.0% | ||
| Q2 25 | 34.4% | 90.8% | ||
| Q1 25 | 37.6% | 90.5% | ||
| Q4 24 | 33.9% | 92.6% | ||
| Q3 24 | 37.2% | 90.1% | ||
| Q2 24 | 37.0% | 89.5% | ||
| Q1 24 | 33.1% | 88.6% |
营业利润率PRGORDDT
| Q4 25 | -116.0% | 31.9% | ||
| Q3 25 | 7.0% | 23.7% | ||
| Q2 25 | 4.3% | 13.6% | ||
| Q1 25 | 4.5% | 1.0% | ||
| Q4 24 | 10.0% | 12.4% | ||
| Q3 24 | 7.4% | 2.0% | ||
| Q2 24 | -2.5% | -11.0% | ||
| Q1 24 | -5.1% | -242.5% |
净利率PRGORDDT
| Q4 25 | -127.8% | 34.7% | ||
| Q3 25 | 0.7% | 27.8% | ||
| Q2 25 | -0.8% | 17.9% | ||
| Q1 25 | -0.6% | 6.7% | ||
| Q4 24 | -3.9% | 16.6% | ||
| Q3 24 | -1.9% | 8.6% | ||
| Q2 24 | -10.2% | -3.6% | ||
| Q1 24 | 0.2% | -236.7% |
每股收益（稀释后）PRGORDDT
| Q4 25 | $-10.23 | $1.24 | ||
| Q3 25 | $0.05 | $0.80 | ||
| Q2 25 | $-0.06 | $0.45 | ||
| Q1 25 | $-0.05 | $0.13 | ||
| Q4 24 | $-0.32 | $4.76 | ||
| Q3 24 | $-0.15 | $0.16 | ||
| Q2 24 | $-0.79 | $-0.06 | ||
| Q1 24 | $0.01 | $-8.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $953.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.9B | $2.9B |
| 总资产 | $8.5B | $3.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRGORDDT
| Q4 25 | — | $953.6M | ||
| Q3 25 | $432.1M | $911.7M | ||
| Q2 25 | $454.2M | $734.1M | ||
| Q1 25 | $409.9M | $635.7M | ||
| Q4 24 | $558.8M | $562.1M | ||
| Q3 24 | $1.5B | $515.9M | ||
| Q2 24 | $542.8M | $468.0M | ||
| Q1 24 | $658.5M | $968.5M |
股东权益PRGORDDT
| Q4 25 | $2.9B | $2.9B | ||
| Q3 25 | $4.4B | $2.6B | ||
| Q2 25 | $4.5B | $2.4B | ||
| Q1 25 | $4.4B | $2.2B | ||
| Q4 24 | $4.3B | $2.1B | ||
| Q3 24 | $4.6B | $2.0B | ||
| Q2 24 | $4.5B | $1.9B | ||
| Q1 24 | $4.7B | $1.8B |
总资产PRGORDDT
| Q4 25 | $8.5B | $3.2B | ||
| Q3 25 | $10.1B | $2.9B | ||
| Q2 25 | $10.1B | $2.6B | ||
| Q1 25 | $9.8B | $2.4B | ||
| Q4 24 | $9.6B | $2.3B | ||
| Q3 24 | $11.2B | $2.2B | ||
| Q2 24 | $10.4B | $2.1B | ||
| Q1 24 | $10.6B | $2.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $175.4M | $266.8M |
| 自由现金流经营现金流 - 资本支出 | $148.6M | $263.6M |
| 自由现金流率自由现金流/营收 | 13.4% | 36.3% |
| 资本支出强度资本支出/营收 | 2.4% | 0.4% |
| 现金转化率经营现金流/净利润 | — | 1.06× |
| 过去12个月自由现金流最近4个季度 | $145.1M | $684.2M |
8季度趋势，按日历期对齐
经营现金流PRGORDDT
| Q4 25 | $175.4M | $266.8M | ||
| Q3 25 | $51.7M | $185.2M | ||
| Q2 25 | $75.9M | $111.3M | ||
| Q1 25 | $-64.5M | $127.6M | ||
| Q4 24 | $312.6M | $90.0M | ||
| Q3 24 | $42.2M | $71.6M | ||
| Q2 24 | $9.5M | $28.4M | ||
| Q1 24 | $-1.4M | $32.1M |
自由现金流PRGORDDT
| Q4 25 | $148.6M | $263.6M | ||
| Q3 25 | $29.8M | $183.1M | ||
| Q2 25 | $56.7M | $110.8M | ||
| Q1 25 | $-90.0M | $126.6M | ||
| Q4 24 | $274.9M | $89.2M | ||
| Q3 24 | $15.1M | $70.3M | ||
| Q2 24 | $-18.9M | $27.2M | ||
| Q1 24 | $-26.5M | $29.2M |
自由现金流率PRGORDDT
| Q4 25 | 13.4% | 36.3% | ||
| Q3 25 | 2.9% | 31.3% | ||
| Q2 25 | 5.4% | 22.2% | ||
| Q1 25 | -8.6% | 32.3% | ||
| Q4 24 | 24.2% | 20.8% | ||
| Q3 24 | 1.4% | 20.2% | ||
| Q2 24 | -1.8% | 9.7% | ||
| Q1 24 | -2.4% | 12.0% |
资本支出强度PRGORDDT
| Q4 25 | 2.4% | 0.4% | ||
| Q3 25 | 2.1% | 0.4% | ||
| Q2 25 | 1.8% | 0.1% | ||
| Q1 25 | 2.4% | 0.2% | ||
| Q4 24 | 3.3% | 0.2% | ||
| Q3 24 | 2.5% | 0.4% | ||
| Q2 24 | 2.7% | 0.4% | ||
| Q1 24 | 2.3% | 1.2% |
现金转化率PRGORDDT
| Q4 25 | — | 1.06× | ||
| Q3 25 | 6.89× | 1.14× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 4.88× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | — | 2.40× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
RDDT
| Advertising | $689.7M | 95% |
| Other Revenue | $35.9M | 5% |
